Skip to main content
Premium Trial:

Request an Annual Quote

Korean NIH Partners with Affy for Genome-Wide Association Studies

NEW YORK, March 8 (GenomeWeb News) - Korea's National Institute of Health will use Affymetrix's Human 500K Mapping Set to perform genome-wide association studies in several disease areas, including diabetes, hypertension, and metabolic syndrome, Affy said today.


According to Affymetrix, the Korean NIH will work with academic and industry partners to generate more than 10 billion individual genotypes from 20,000 human DNA samples to help identify the genetic causes of these diseases using Affy's technology.


Financial details of the agreement were not discussed.